Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Merck's animal health division, which develops vaccines and medicines for dogs, cats and cattle, posted nearly $1.4 billion in sales, up 9% from the same period a year ago. The company said higher ...